Retrospective study of the immunogenicity and safety of the CoronaVac SARS-CoV-2 vaccine in people with underlying medical conditions

BACKGROUND: People living with chronic disease, particularly seniors (≥60 years old), made up of most severe symptom and death cases among SARS-CoV-2 infected patients. However, they are lagging behind in the national COVID-19 vaccination campaign in China due to the uncertainty of vaccine safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunmei, Bi, Hanfang, Fu, Zhenwang, Li, Ao, Wan, Na, Hu, Jun, Yang, Fan, Zhou, Tai-Cheng, Liang, Yupeng, Su, Wei, Shi, Tianpei, Yang, Mei, Wang, Rong, Qin, Wanting, Yu, Xuanjing, Zheng, Hong-Yi, Zhou, Zumi, Zheng, Yong-Tang, Wei, Jia, Zeng, Gang, Zhang, Zijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700702/
https://www.ncbi.nlm.nih.gov/pubmed/36434092
http://dx.doi.org/10.1038/s43856-022-00216-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700702/
https://www.ncbi.nlm.nih.gov/pubmed/36434092
http://dx.doi.org/10.1038/s43856-022-00216-2

Ejemplares similares